|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM039445437 |
| 003 |
DE-627 |
| 005 |
20250127035946.0 |
| 007 |
tu |
| 008 |
231221s1986 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed25n0132.xml
|
| 035 |
|
|
|a (DE-627)NLM039445437
|
| 035 |
|
|
|a (NLM)3963297
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Taya, C
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Effect of H-2 complex on the growth of embryo-derived teratomas in mice
|
| 264 |
|
1 |
|c 1986
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 07.05.1986
|
| 500 |
|
|
|a Date Revised 30.10.2019
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Seven-day-old embryos of several H-2 congenic strains were transplanted under the kidney capsules of syngeneic adult recipients to determine the genetic factors(s) governing the in vivo growth of embryo-derived teratomas. A.TH(H-2t2) and A.TL(H-2t1) strains showed significantly greater tumor weights than A.BY(H-2b) and A.SW(H-2s) strains. The A(H-2a) strain was intermediate in tumor size. A comparison of the genic constitution of the H-2 complex in each congenic strain suggested that the H-2D locus and/or its distal regions affected the growth of embryo-derived teratomas. The teratoma induced in the B10.A(H-2a) strain was smaller than that in the A(H-2a) strain, indicating that the genetic background of the A strain is favorable for teratoma growth. Histological observations demonstrated that the existence of embryonal carcinoma cells was necessary for the growth of teratomas. A radiation-sensitive immunological factor in the recipient probably plays a role in stimulating teratoma growth
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a H-2 Antigens
|2 NLM
|
| 700 |
1 |
|
|a Moriwaki, K
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|a Lee, C S
|t Malignant potential of aneuploid pancreatic endocrine tumours
|d 1993
|g 10(1986), 2 vom: 15. Feb., Seite 35-8
|w (DE-627)NLM023911689
|
| 773 |
1 |
8 |
|g volume:10
|g year:1986
|g number:2
|g day:15
|g month:02
|g pages:35-8
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_92
|
| 912 |
|
|
|a GBV_ILN_110
|
| 912 |
|
|
|a GBV_ILN_131
|
| 912 |
|
|
|a GBV_ILN_203
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_606
|
| 912 |
|
|
|a GBV_ILN_657
|
| 912 |
|
|
|a GBV_ILN_791
|
| 912 |
|
|
|a GBV_ILN_1016
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 10
|j 1986
|e 2
|b 15
|c 02
|h 35-8
|